Lupin Limited has informed the Exchange regarding a press release dated February 09, 2023, titled "Lupin Receives Approval from U.S. FDA for Glycopyrrolate Injection, USP.".
Lupin Limited has informed the Exchange regarding a press release dated February 09, 2023, titled "Lupin Receives Approval from U.S. FDA for Glycopyrrolate Injection, USP.".